to tissue damage when aberrantly activated. In higher organisms, cytoplasmic DNA can trigger inflammation that can lead to tissue degeneration. Simpler in vivo models could shed new mechanistic light on how inflammatory responses to cytoplasmic DNA lead to pathology. Here we show that in DNase IIdeficient Caenorhabditis elegans, persistent foreign cytoplasmic DNA leads to systemic tissue degeneration, and we identify impaired protein homeostasis as an inflammatory pathomechanism. This pathological outcome can be alleviated by improving protein homeostasis, either via ectopic induction of the endoplasmic reticulum unfolded protein response (UPR ER ) or by treatment with Nacetylglucosamine. Our results establish C. elegans as an ancestral metazoan model for studying outcomes of inflammation-like conditions caused by persistent cytoplasmic DNA and provide insight into potential therapies for conditions involving chronic inflammation.
using an Axio Observer A1 (Zeiss) and FemtoJet (Eppendorf) equipped with Femtotip II needles ( Figure   1A ) (for detailed methods, see Materials and Methods) . To monitor the location and success of the injection, the fluorescent compound rhodamine-isothiocyanate dextran (10,000 MW) was included in the injection mixture, as it is commonly used for this purpose since it is generally inert in cells and has limited ability to diffuse (Schmued et al., 1990) .
To monitor consequences of DNA injections on the overall health of the animals we measured pharyngeal pumping, which is an established and highly sensitive method for monitoring even small changes in tissue functionally during aging (Bolanowski et al., 1981; Chow et al., 2006; Huang et al., 2004) , following induction of DNA damage (Wilson et al., 2017) , and during infection (O'Quinn et al., 2001; Tan et al., 1999) . DNase II-defective worms have been previously shown to induce a mild immune response, even in the absence of a pathogen (Yu et al., 2015) ; therefore, we suspected that a DNase II-mutant strain (in this case carrying the nuc-1(e1392) allele (Wu et al., 2000) ) may be a useful tool for our experiments. In wildtype worms, we did not observe any change in the pumping rate following injection of E. coli genomic DNA; however, identical injection into DNase II-deficient worms, in which the DNA should persist, led to a statistically significant decline in the pumping rate over the course of 72 hours post-injection ( Figure 1B) . Importantly, such a difference in pumping rates was not observed in either un-injected animals or animals injected with the co-injection marker alone ( Figure 1C and 1D ).
Injection of whole E. coli genomic DNA proved technically challenging, as its large molecular weight tended to clog the microinjection needles; therefore, we switched to low molecular weight CpG-rich synthetic oligonucleotides (ODNs). As shown in Figure 1E , injection of a CpG-containing ODN (ODN 2395) led to a similar pumping rate decline. In contrast to the results obtained with E. coli genomic DNA, a slight reduction of the pumping rate of wildtype worms resulted after ODN injection. We attribute this difference to increased resistance of the ODNs to DNase digestion due to phosphorothioate linkages in the ODN backbone.
A common feature shared between the E. coli genomic DNA and the synthetic ODNs is the presence of CpG sites. In higher organisms, CpG-containing DNA introduced by bacterial pathogens can be sensed by the toll-like receptor (TLR) 9 to induce an immune response. We supposed that a similar process might occur in C. elegans; to test this hypothesis, we compared the effects of a CpG-containing ODN (as in Figure   1E ) to non-CpG control ODNs (ODN 5328) (which are non-antagonistic for mammalian TLR9) ( Figure   1F , top). As shown in Figure 1F (bottom), injection of the control ODN caused a milder decrease in pumping rate, suggesting that worms have a more robust response to CpG-containing DNA. This finding makes an important connection between the responses of worms and higher organisms to foreign DNA.
Cytoplasmic DNA accumulates in intestinal cells during infection with uropathogenic E. coli (UPEC) and results in a systemic health decline
A limitation of our injection experiments was that we could introduce only small amounts of foreign DNA into the intestinal cells, likely preventing the detection of more robust effects on the animals that could result from higher loads of cytoplasmic DNA; therefore, a means of introducing larger amounts of DNA could be useful. Some pathogenic E. coli, including some UPEC strains, can invade host cells (Lewis et al., 2016) ; therefore, we predicted that infection of the intestinal lumen of a DNase II-defective mutant worm strain with UPEC might provide such a possibility. We obtained a clinical UPEC isolate (designated ECO85) and infected worms via feeding. To determine if bacterial DNA accumulated in the cytoplasmic of UPEC-infected worms, we stained dissected intestinal cells with 4ʹ,6-diamidino-2-phenylindole (DAPI) to examine the DNA content of the cells. Confocal imaging (Figure 2A (Figures 2A-C) . The observation that both wildtype and DNase II-deficient worms contain such bodies suggests that the bacterial DNA is introduced into the cells of both worm strains, but that it persists more robustly in the DNase II-defective strain. Notably, similar DAPI-stained bodies were not observed in DNase II-deficient animals grown on the non-pathogenic E. coli strain OP50 (Supplemental Figure 1 ). Interesting, we were not able to identify any other bacterial components in the cytoplasm of the intestinal cells using anti-E. coli antibodies or transmission electron microscopy (TEM), arguing against direct cellular invasion; however, it is now clear that bacterial DNA can enter cells via outer membrane vesicles (OMVs) and that is persists (Bitto et al., 2017) . Therefore, we propose that the bacterial DNA may enter the cells as cargo in OMVs, although this question remains to be fully addressed. We were next curious if the persistent foreign DNA introduced via UPEC infection may lead to preferential declines in tissue integrity and functionality in the DNase II-deficient worms compared to wildtype worms. To address this question, we looked at several indicators of health in the worms: (1) pharyngeal pumping rate; (2) intestinal tissue integrity; (3) muscle integrity; and (4) reproductive function.
The pharyngeal pumping rate was measured (as above) during the first five days after UPEC infection. As shown in Figure 3A , UPEC infection led to a more rapid decline in the pumping rate in wildtype and DNase II-deficient worms compared to animals reared on E. coli OP50 (the normal food source for C. elegans); however, this effect was much more severe in the DNase II-deficient animals. We confirmed this effect with two alleles of nuc-1: e1392 and n887. The variation between the phenotypes following injection and infection could be due to differences in the amount of cytoplasmic DNA delivered into the intestinal cells in each technique, as injected worms -which receive much less DNA -showed a smaller pumping rate decline ( Figure 1) .
Changes in pharyngeal pumping in C. elegans can be attributed either to behavioral changes (reviewed in (Luedtke et al., 2010) ) or to loss of tissue functionality. The validity of our pumping assay to address our experimental questions depends on the latter possibility; therefore, we wanted to confirm that the integrity of the pharynx was preferentially compromised in the UPEC-infected DNase II-defective worms. We imaged worms using differential interference contrast (DIC) microscopy four days after infection (example images are provided in Figure 3c ) and then measured the surface areas of the pharyngeal metacorpus and posterior bulb in each worm (explained in more detail in Supplemental Figure 1) . These values were added and plotted in arbitrary units as shown in Figure 3d . Indeed, we observed a pronounced and statistically significant decrease in surface area in the nuc-1 mutant animals fed UPEC compared to the nuc-1 animals fed OP50. No significant difference was observed under the same conditions in the wild type worms. These results demonstrate that the pumping rate declines in our experimental system are the result of pharyngeal atrophy and not behavioral changes; therefore, this assay provides a reliable and quantitative metric for tissue functionality. Figure 4 shows images of the anterior sections of intestines (adjacent to the pharynx) in animals stained with the dyes acridine orange (AO) or Nile red (NR), both of which accumulate in punctate intracellular acidic compartments (Clokey and Jacobson, 1986; O'Rourke et al., 2009) . Dissolution of the punctate bodies is a hallmark of necrotic cell death and can be used as a marker for tissue integrity during pathogen infection (Zou et al., 2014) . The intestines of wildtype and DNase II-deficient worms grown on E. coli OP50 show accumulations of AO and NR in highly resolved punctate bodies, as expected for healthy animals ( Figure 4A and B). After 72 h of UPEC infection, these compartments lose their punctate definition preferentially in the DNase II-deficient animals (Figure 4C and D) . As the severity of this effect can be variable after infection, two animals are shown as representative examples for the AO staining with UPEC infection.
We used two approaches to examine body wall muscle integrity: locomotion (crawling speed) and phalloidin staining of F-actin (Francis, 1985; Wulf et al., 1979) . As shown in Figure 5A , UPEC infection led to a more severe impairment of crawling speed in the DNase II-deficient worms compared to the wildtype worms. This effect could be due either to a behavioral change or to muscle degeneration. To distinguish these possibilities, we stained the F-actin in the body wall muscles used for crawling. Consistent with a decline in tissue integrity, the phalloidin staining revealed increased disorganization of the F-actin in the UPEC-infected worms compared to normally fed wildtype or DNase II-defective animals ( Figure   5B ). The white dashed lines outline individual muscle cells clearly showing atrophy and loss of F-actin organization most severely in the UPEC-infected, DNase II-defective animals.
Lastly, we examined reproductive function by measuring the fecundity of infected worms. While wildtype and DNase II-deficient worms have nearly identical progeny production when reared on E. coli OP50 ( Figure 5C -left), UPEC-infected DNase II-deficient worms showed decreased egg production, especially during the first two days of egg laying ( Figure 5C -right). Taken together, these results show that UPECinfected DNase II-deficient worms suffer from profound systemic declines in tissue integrity and stability that is largely absent in the wildtype worms, suggesting that DNase II provides a protective effect during UPEC infection. Importantly, these phenotypes are reminiscent of the types of tissue decline associated with chronic inflammation in mammals indicating that C. elegans might be useful as a model for studying the effects of chronic inflammation associated with ectopic DNA.
Disruption of the FSHR-1 innate immune signaling pathway rescues the tissue degeneration phenotype
One possibility to explain the observed tissue degeneration phenotypes is the aberrant induction of an uncontrolled immune response; if this hypothesis is true, then abrogating the response should alleviate the tissue decline in worms challenged with UPEC infection or cytoplasmic foreign DNA. The C. elegans p38 MAP kinase homolog PMK-1 is an important mediator of the innate immune response to a variety of pathogens (Kamaladevi and Balamurugan, 2015; Kim et al., 2002) ; thus, we first tested if it is involved in these phenotypes. RNAi-mediated depletion of PMK-1 did not rescue the pumping rate decline observed in nuc-1 worms injected with CpG ODNs ( Figure 6A ). Thus, we conclude that p38/PMK-1 does not control the response to foreign cytoplasmic DNA.
We next shifted our attention to another previously identified central immune regulator: the leucine-rich repeat (LRR)-containing protein FSHR-1, which regulates an immune response to several different pathogens in parallel to the p38/PMK-1 pathway (Powell et al., 2009) . We tested for a role of FSHR-1 in our experimental system via RNAi-mediated depletion of FSHR-1 in wildtype and nuc-1 worms. The worms were then either injected with CpG ODNs or infected with UPEC and the pharyngeal pumping rates were scored up to 96 h post-treatment. As shown in Figure 6B , FSHR-1 depletion in nuc-1 worms eliminated the pumping rate decrease caused by injection of CpG ODNs into intestinal cells ( Figure 6B ).
We also confirmed these phenotypes using UPEC infection. Depletion of FSHR-1 imparted no benefit to the UPEC-infected wildtype worms between 72 and 96 h ( Figure 6C ); in fact, the wildtype; fshr-1(RNAi) worms had decreased pumping rates at the early time points, suggesting that FSHR-1 might control a rapid beneficial response to the pathogen. In contrast, UPEC-infected nuc-1; fshr-1(RNAi) worms showed robust improvements in their pumping rates at the later time points of infection that were similar to wild-type rates ( Figure 6D ). As in the wildtype worms, FSHR-1 depletion in nuc-1 worms also had a slight negative effect on pumping rate at the 24 h time point. To further confirm the presence of an innate immune response, we tested the expression levels of several previously identified immune-associated genes by RT-qPCR and found that their expression was indeed induced, both after UPEC infection and DNA injection (Supplemental Figure 2 ). Taken together, these results suggest that FSHR-1 regulates a beneficial early response to infection that is common between wildtype and nuc-1 worms (most likely independent of foreign DNA), but that FSHR-1 activity is the primary, if not the sole, mediator of the response to persistent foreign cytoplasmic DNA.
Chronic UPEC infection leads to a disruption of protein homeostasis
We next set out to clarify the basis of the increased sensitivity of the DNase II-deficient worms to cytoplasmic DNA (either directly injected or introduced via UPEC infection). Immunity-associated stress responses in C. elegans result in induction of a large number of putative secreted peptides (Shivers et al., 2008) and deregulation of the response can be detrimental to C. elegans (Cheesman et al., 2016) . One hypothesis to explain the preferential tissue degeneration in DNase II-deficient worms is that persistent cytoplasmic DNA leads to a prolonged upshift in the production of secreted proteins that could strain the animal's protein quality control mechanisms to the point that proteotoxic effects cause cellular damage. This hypothesis is supported by the previous observation that the UPR ER is required by worms to tolerate the innate immune response to the pathogen Pseudomonas aeruginosa (Richardson et al., 2010) , and that the UPR may assist in activation of the immune response (Dai et al., 2015) .
As our first approach to look for effects on protein homeostasis, we used transmission electron microscopy to directly examine the ER structure and ribosome content in the intestinal cells. As can be seen in Figure   7A , the ER of wildtype worms, either mock infected with E. coli OP50 or infected with UPEC, appears normal with a regular distribution of ribosomes around the ER cisternae (see high magnification images, blue arrows). In contrast, the DNase II-deficient worms infected with UPEC showed enlarged cisternal spaces, a typical hallmark of ER disruption (Richardson et al., 2010) . Furthermore, the distribution of the ribosomes around the cisternae was irregular (compare regions indicated by red arrows to those indicated by blue arrows), especially in infected DNase II-deficient worms.
Physical disruption of the ER could be associated with defects in protein folding, which would normally lead to compensatory activation of the UPR ER . To evaluate the status of the UPR ER , we measured the relative levels of the unspliced (unspl.) and spliced (spl.) forms of the xbp-1 transcript (Yoshida et al., 2001) .
Splicing of xbp-1 leads to the production of the active form of XBP-1, a transcription factor that acts as a central regulator of the UPR ER ( Figure 7B ). RNA was collected from wildtype and DNase II-deficient worms 24 and 48 h after infection with UPEC. As shown in Figure 7C , the level of spliced xbp-1 transcript is not significantly increased under any condition and, importantly, the expression of hsp-4, a prototypical XBP-1 target gene (see Figure 7B ), is also not induced. These results suggest two mutually exclusive possibilities: (1) Despite disruption of the ER, no compensatory activation of the UPR ER occurs, or (2) that the response is activated, but is not sufficiently sustained during the course of the infection to provide a long-term protective effect. We conclude from these results that a response by the DNase II-deficient worms to UPEC infection strains the protein quality control pathways leading to unresolved protein-folding stress in the ER (due to failure to activate the UPR ER ) and that ensuing proteotoxic effects could ultimately lead to the tissue degeneration in DNase II-deficient animals due to the accumulation of cytoplasmic DNA.
These results are consistent with the toxicity of an aberrantly activated innate immune response in C.
elegans (Cheesman et al., 2016) .
Therapeutic improvement of ER protein homeostasis alleviates the tissue functionality decline caused by persistent cytoplasmic DNA
If a chronic, unresolved defect in ER homeostasis due to failure to induce or sustain the UPR ER drives the tissue degeneration in the presence of persistent cytoplasmic DNA, we wondered if exogenous, sustained activation of the UPR ER or enhancement of the ER protein folding capacity could alleviate the tissue degeneration. To examine these possibilities, we used three distinct approaches: (1) ectopic activation of the UPR ER via mild, subtoxic, chemically-induced protein folding stress ( Figure 8A ); (2) activation of the UPR ER independent of protein folding stress ( Figure 8D ); and (3) therapeutic enhancement of protein folding capacity in the ER ( Figure 8F ).
We first used a continuous low dose (0.5 µg/mL) treatment with tunicamycin during the course of UPEC infection and after DNA injection. Tunicamycin inhibits protein glycosylation, which leads to subsequent induction of the UPR ER (King and Tabiowo, 1981 )( Figure 8A ). Wildtype worms treated with tunicamycin during UPEC infection showed no improvement in pharyngeal pumping over 96 h of infection, although they still showed an infection-dependent health decline ( Figure 8B -left). In stark contrast, tunicamycin treatment of UPEC-infected DNase II-deficient worms reverted the decreased pumping rate to a level similar to infected wildtype worms ( Figure 8B -right) . Remarkably, tunicamycin treatment also completely eliminated the pumping rate decline caused by ODN injection into the intestine of DNase II-deficient animals ( Figure 8C ). These results, in particular the rescue of the injection effect, suggest that exogenous activation of the UPR ER can resolve the detrimental consequences of persistent cytoplasmic DNA.
Because tunicamycin interferes with post-translational processing and can be toxic (Denzel et al., 2014; King and Tabiowo, 1981) , we wanted to confirm that its beneficial effect was due the induction of UPR ER and not to off-target effects. To this end we sought an alternative experimental strategy to activate the UPR ER without affecting the protein homeostasis systems. Loss of the S-adenosylmethionine synthase SAMS-1 leads to induction of the UPR ER by inducing lipid disequilibrium in the ER without introducing protein folding stress (Hou et al., 2014 ) ( Figure 8D ). Mirroring the tunicamycin results, RNAi-mediated depletion of sams-1 led to a similar rescue of the decline in tissue functionality after UPEC infection in DNase II-deficient worms and provided little or no benefit for wildtype worms ( Figure 8E ). While sams-1 has been previously assigned a function in immunity (Ding et al., 2015) , a general change in proteostatic status is unlikely here since the effect of infection on the wildtype strain was minimal, and the beneficial effect was only observed in the DNase II-deficient strain. We conclude from these experiments that mild ectopic induction of the UPR ER can relieve the proteotoxic outcomes from an upshift in protein synthesis associated with the worm's stress response pathways.
Tunicamycin treatment and SAMS-1 depletion activate the UPR ER via disruption of normal cellular processes (protein glycosylation and lipid homeostasis, respectively). We next wondered if protection of ER function without such side effects could also provide protection against tissue degeneration in DNase II-deficient worms. Treatment of C. elegans with N-acetylglucosamine (GlcNAc) slows ageing and suppresses proteotoxic effects of aggregating proteins by augmenting the hexosamine pathway, which enhances protein folding and improves ER homeostasis (Denzel et al., 2014) ( Figure 8F ). To test whether GlcNAc treatment can protect DNase II-deficient worms from the detrimental effects of cytoplasmic DNA, we treated DNase II-deficient animals with 10 mM GlcNAc after ODN injection. As shown in Figure 8G , constant exposure to GlcNAc following the ODN injection eliminated the tissue functionality decline caused by DNA injection; thus, enhancement of the ER protein folding capacity through this non-toxic pharmacological approach can offer a similar benefit to tunicamycin treatment and SAMS-1 depletion.
Finally, we were interested in whether tunicamycin treatment could be used as a curative intervention to provide a therapeutic benefit during ongoing infection. To test this possibility, we transferred infected worms from plates containing only UPEC to plates that additionally contain 0.5 µg/mL tunicamycin at regular intervals up to 72 h post-infection and measured the pumping rates on the following days up to 120 h post-infection (outlined in Figure 8H ). Remarkably, DNase II-deficient worms transferred to tunicamycin plates as late as 72 h post-infection showed significant improvement in the pumping rates ( Figure 8I right). Further supporting the conclusion that wildtype worms are not subject to the same unresolved ER stress, transfer to tunicamycin offered them no advantage ( Figure 6I Figure 3A ). Based on these results, we conclude that mild induction of the UPR ER can provide a protective effect during an ongoing immunogenic challenge that induces proteotoxic stress.
DISCUSSION
Many open questions remain about the mechanisms of sensing and responding to cytoplasmic pathogenic DNA. Perhaps more enigmatic are the mechanisms through which chronic innate immune responses lead to tissue damage. Furthermore, our repertoire of therapeutic options for alleviating these detrimental outcomes is limited. In this study, our goal was to establish C. elegans as a simple metazoan model to further explore how animals respond to cytoplasmic DNA and to better understand the effects chronic activation of the downstream responses at the cellular and organismal levels. Our ultimate goal was to develop interventions to support tissue preservation and functionality under such conditions.
The nematode innate immune response has been extensively investigated, and several key regulators that mediate systemic responses to bacteria and fungi have been well documented (Ermolaeva and Schumacher, 2014; Kim et al., 2002; Kim and Ewbank, 2018; Powell et al., 2009) . However, what is entirely lacking in the C. elegans field are data on whether the worm can sense and respond to cytoplasmic DNA. None of the known DNA-sensing pathways identified in higher eukaryotes are conserved in C. elegans. While the C.
elegans genome does encode one Toll-like receptor (TOL-1) (Pujol et al., 2001) , it appears to have a limited role in immunity (Battisti et al., 2017; Galbadage et al., 2016; Rangan et al., 2016; Tenor and Aballay, 2008) ; furthermore, the immune functions it does have may operate through a developmental function (Brandt and Ringstad, 2015) . The absence of these systems suggests that C. elegans may possess alternative and novel pathways to fulfill this important defense function. In this study, we demonstrated that C. elegans can indeed mount a response to foreign cytoplasmic DNA, and that when this response is chronically activated it can lead to severe multi-system declines in tissue stability and functionality. After identifying the sub-cellular effects responsible for these declines, we successfully developed simple interventions that alleviate these effects, which may also be applicable to higher organisms, including humans. It is this novel therapeutic perspective supplied by our study that we believe could have the most impact on human health as these approaches are refined.
Upon introduction of foreign DNA into the cytoplasm of worm intestinal cells, either by direct microinjection or via infection with a uropathogenic E. coli (UPEC) strain isolated from a human patient ( Figures 1, 2 and 3) , we observed only a mild effect after UPEC infection and almost no effect after DNA injection in wild type worms. The decreased survival caused by the UPEC strain is likely due to effects of bacterial colonization of the intestine and incomplete host-mediated immunity. However, a different story emerged in a strain lacking DNase II, encoded by nuc-1 in C. elegans. Introduction of pathogenic DNA into the cytoplasm of the intestinal cells these worms led to profound declines in tissue stability and functionality that worsened over the course of several days. An unexpected outcome of the introduction of foreign DNA was that tissues distal to the intestinal, including the pharynx (Figures 1 and 3) , the muscles ( Figure 5A and B) , and the reproductive system ( Figure 5C ), were severely affected. One explanation for these phenotypes is that the expression levels of many secreted factors increase during the nematode innate immune response (Kato et al., 2002; Mallo et al., 2002; Schulenburg et al., 2004) and that these factors can, when chronically expressed, have detrimental effects throughout the body. We propose that these effects are reminiscent of the tissue damage that occurs during chronic inflammatory responses in mammals, including humans.
Dysregulation of the p38/PMK-1-mediated response to P. aeruginosa, in the form of chronic induction, is toxic to worms (Cheesman et al., 2016) . Moreover, in developing worms the UPR ER is required for survival during P. aeruginosa infection (Richardson et al., 2010) . These observations prompted us to investigate whether the chronic response to pathogenic DNA could disrupt protein homeostasis. To explore this question, we used transmission electron microscopy to examine the structure of the ER ( Figure 7A ) and molecular and cellular techniques to examine the function of the UPR ER ( Figure 7B ). We observed that not only was the superstructure of the ER disrupted (a previously characterized feature of impaired protein homeostasis (Richardson et al., 2010) , but that the UPR ER was not active during chronic (on the scale of days) exposure to cytoplasmic DNA. One possible explanation that we favor is that the UPR ER may be activated during the initial phase of the response, but that it cannot be maintained when the immune response becomes chronic. The lack of this ongoing compensatory response as well as the burden of the enhanced gene expression likely lead to proteotoxic effects that we believe are the sub-cellular basis for the observed tissue degeneration.
We also explored interventions that if successful in alleviating these detrimental effects, would substantiate the functional role of the UPR ER and potentially precipitate novel anti-inflammatory therapeutic routes.
First, we attempted to entirely ablate the underlying immune response by eliminating the most likely immune regulators ( Figure 6 ). We depleted two of the key response regulators, PMK-1 and FSHR-1, and challenged the worms with pathogenic cytoplasmic DNA. Loss of PMK-1 in the DNase II-deficient worms had no effect on the tissue degeneration phenotype; in contrast, loss of the G protein-coupled receptor FSHR-1 (Powell et al., 2009) robustly alleviated the phenotype. Through this experiment, we confirmed that chronic activation of the FSHR-1-mediated immune response indeed underlies the tissue degeneration phenotype, and we propose FSHR-1 as the likely mediator in the response to pathogenic cytoplasmic DNA.
Given the structure of the leucine-rich repeats in FSHR-1 that are also present in mammalian toll-like receptors, it is not inconceivable that this immune signaling component might even function as sensor of cytoplasmic DNA. Based on our observation of ER disruption and a lack of sustained UPR ER induction (Figure 7) , we used three mechanistically independent approaches that improve protein homeostasis with the goal of reducing the toxicity of the chronic response ( Figure 8 ). We exposed the worms to low, subtoxic levels of tunicamycin, a chemical that robustly activates the UPR ER by interfering with N-linked glycosylation of newly translated proteins. This treatment induced a profound rescue of the tissue degeneration phenotype in the DNase II-deficient worms exposed to pathogenic DNA. We suggest that this treatment constitutively activates and maintains the UPR ER during the entire course of the chronic response, and that this ongoing compensatory response rescues the tissue degeneration phenotype. As an alternative genetic approach, we depleted the S-adenosyl methionine synthetase SAMS-1 via RNA interference. Loss of SAMS-1 is known to enhance protein homeostasis without inducing proteotoxic stress (in contrast to tunicamycin). Similarly, SAMS-1 depletion also rescued the tissue degeneration phenotype. As both tunicamycin exposure and SAMS-1 depletion inhibit fundamental cellular processes to induce the UPR ER , we wanted to explore a completely non-toxic approach. Treatment with N-acetylglucosamine (GlcNAc 2010). Furthermore, enhanced ER homeostasis has recently been shown to enhance the animals' tolerance of the innate immune response (Tillman et al., 2018) . These outside observations further substantiate our model, which is outlined in Figure 9 .
We believe that the identification of therapeutic approaches that alleviate the outcomes of the chronically activated innate immune response may have the most importance from the perspective of human health.
Treatment with low concentration of tunicamycin (which has been shown to be well tolerated by mice (Wang et al., 2015) ) or GlcNAc had robust protective effects in the DNaseII-deficient worms following UPEC infection or intestinal DNA injection. The dependence of this rescue on the absence of DNase II together with our ability to rescue the phenotype via disruption of innate immune signaling, strongly supports that these outcomes are, indeed, a direct result of a systemic response to the pathogenic DNA; thus, we demonstrate for the first time that C. elegans does mount a response to cytoplasmic DNA.
Furthermore, we propose that the tunicamycin-induced protection occurs via low-level UPR ER activation, and that the enhanced protein folding capacity afforded by GlcNAc helps to maintain ER functionality. The net outcome of each interventions is an amelioration of the proteotoxic effects resulting from the chronic immune response. These findings may have important implications for the understanding of DNASE2related inflammatory conditions in humans. ER stress has been shown to be a mediator of kidney injury (reviewed in (Inagi, 2009 )), and tunicamycin injection reduced the severity of the inflammatory kidney disease in a mouse model for mesangioproliferative glomerulonepthritis (Inagi et al., 2008) . These observations provide additional support for our hypothesis that mild UPR ER induction may provide protection in the face of the significant upshift in protein expression involved in inflammatory responses.
Therefore, we propose that therapeutic protection of ER functionality in patients with inflammatory conditions, such as rheumatoid arthritis and inflammation-induced heart failure, may offer a similar benefit.
The innate immune response also puts significant strain on the host's cells and the ensuing inflammation can result in tissue damage (Wallach et al., 2014) . Inflammation can disrupt tissue functionality and, when chronically active, can contribute to the aging process (Pawelec et al., 2014) . Inflammatory processes are associated with a wide range of human disorders including bowel disease (Hanauer, 2006 ), arthritis (Firestein, 2003 , and heart failure (Oka et al., 2012) . It is, thus, of pivotal importance to better understand the molecular mechanisms how the innate immune responses result in inflammation. The characterization of this new tissue degeneration phenotype in worms, which we propose can serve as a model for inflammation-associated tissue degeneration in higher animals, as well as our identification of a previously unknown response to persistent cytoplasmic pathogenic DNA establishes C. elegans as an ancestral model for investigating inflammatory responses and for determining the role of protein quality mechanisms in counteracting the detrimental consequences of inflammation. We suggest that further exploration of these processes in this metazoan model will provide new perspectives into the cellular and organismal responses to pathogenic DNA and persistent challenges to the innate immune system. or fshr-1. c. and d. Plots of the pharyngeal pumping rates of wt and nuc-1 worms infected with UPEC with and without RNAi against fshr-1. In all cases, the error bars show the means ± S.D. For a. and b., the statistical significance of differences in the trends between the control and experimental groups were assessed using two-way ANOVA. For c. and d., the statistical significance was assessed using unpaired, two-tailed Student's t tests. In all cases, n.s. P > 0.05, * P < 0.01, ** 0.01 > P > 0.001, *** P < 0.001. Representative images of wt (a) and nuc-1 (b) worms infected with UPEC for 72 h before 48 h of tunicamycin treatment (0.05 µg/mL) with continuous UPEC exposure.
EXPERIMENTAL PROCEDURES
Strain maintenance. Unless otherwise indicated (see pathogen infection methods), all strains were maintained as described at 20 °C (Brenner, 1974) . E. coli strain OP50 was used for routine feeding. The N2 Bristol strain is used as the wildtype control. Other strains used in this study:
CB1392
nuc-1(1392) X. MT1902
nuc-1(e887) X.
Except for where indicated in Figure 3 , the nuc-1(e1392) allele is used throughout.
RNAi treatment. RNAi feeding vectors for fshr-1, pmk-1, and sams-1 were obtained from the Ahringer RNAi library (Source Bioscience, Nottingham, United Kingdom). RNAi feeding E. coli strains were cultured as follows: An overnight culture in LB liquid supplemented with ampicillin (0.1 mg/mL) was inoculated from a frozen stock and incubated for 37 °C overnight with vigorous aeration. This culture was diluted 1:1000 in fresh medium and grown to an OD 600 of about 0.6 under similar conditions. At this time,
IPTG was added to a final concentration of 2 mM and the cultures were incubated for an additional 3 h. 0.2 mL of this culture was then added to NGM plates supplemented with the same concentration of IPTG and grown overnight at 37 °C. For sams-1, L2/L3 worms were fed RNAi for 10 hours prior to infection as L4.
Microinjection. Worms were picked the day before injection at L4 larval stage and grown overnight at 20° C on NGM plates seeded with OP50. The general methodology followed is described in detail in (Rieckher and Tavernarakis, 2017) . The next morning, the young adult worms were transferred into halocarbon oil (Sigma, St. Louis, MO) on a 2% agarose pad for immobilization and injection. Microinjections were performed using an Axio Observer A1 (Zeiss) and FemtoJet (Eppendorf, Hamburg, Germany) microinjection system. Femtotips II (Eppendorf) were used for the injection and the fluorescent dye conjugate rhodamine B isothocyanate-dextran (10,000 MW) (Sigma) was used to track the injection at a concentration of 6 mg/mL in egg salts buffer. DNA from the pathogenic E. coli strain ECO85 was purified using the Puregene Core Kit A (Qiagen, Hilden, Germany) and injected at a concentration of 8 µg/µl and the synthetic CpG oligodeoxyribonucleotide ODN 2395 (Miltenyi Biotec, Bergisch Gladbach, Germany) was injected at a concentration of 100 ng/µl. All injections were made directly into a single intestinal cell.
Following injection, the worms were washed with a mixture of M9 buffer and antibiotics (0.1 mg/mL streptomycin and 0.1 mg/mL gentamycin) to minimize contamination. 50 µl of the antibiotic solution was placed onto an empty NGM plate and up to 20 worms were placed in the liquid, which was allowed to completely soak into the agar. The worms were then transferred onto NGM plates seeded with E. coli OP50.
Next, the worms were sorted using an Axio Zoom.V16 (Zeiss, Jena, Germany) (Schindelin et al., 2012) by drawing a circle around the pharyngeal metacorpus and posterior bulb to establish to regions of interest (ROIs) and then using the "Measure" function to determine their surface areas. The surface areas of the two ROIs in each worm were added, and the statistical analysis was performed on the combined values determined for each worm. The differential interference contrast (DIC)
images of the pharynxes were collected using an AxioImager.M2 (Zeiss) and Zen Pro 2012 software (Zeiss). See also Supplemental Figure 1 for further description.
In vivo staining. Nile Red powder (Sigma) was dissolved in acetone at a concentration 500 µg/ml. For treatment, this stock solution was diluted in 1X phosphate buffered saline (PBS) and pipetted onto NGM plates that were plates previously seeded with either OP50 or ECO85 (prepared as described in the UPEC infection experiment) to a final concentration of 0.05 µg/ml. Worms were transferred to these plates as L4 larvae (as in the UPEC infection experiment). Nile Red staining was monitored was monitored by fluorescence microscopy using AxioImager.M2 (Zeiss) and Zen Pro 2012 software (Zeiss). Acridine orange (AO) solution (Sigma) was diluted to a final concentration of 50 µg/mL in M9 buffer. Worms were picked from plates into M9 buffer and rinsed three times and then transferred into the AO solution. Following a 2 h incubation at 20 °C, the worms were transferred to NGM plates seeded with OP50 for 3 h for "destaining."
The AO staining was then monitored using AxioImager.M2 (Zeiss) and Zen Pro 2012 software (Zeiss).
Immunofluorescence and confocal imaging. After 72 h of feeding on ECO85, N2 and nuc-1(e1392) worms were picked into 1 mL of M9 buffer and rinsed to remove excess bacteria. The intestines were then isolated vie decapitation in egg salts buffer with 0.2% Tween 20 (Roth). Tissue was fixed for 5 minutes in 3.7% formaldehyde (Roth) before being freeze cracked (Strome and Wood, 1982) . The fixed tissues were treated with ice cold 100% methanol for 10 min. Following rinsing in PBS + 1% Triton X-100 (Roth) (PBSTX) and PBS + 0.1% Tween 20 (PBST) the samples were blocked for 1 h with normal donkey serum (NDS) (Sigma) diluted 1:10 in PBST before staining with antibody raised in mouse against α-tubulin Tunicamycin treatment. Tunicamycin (Sigma) dissolved in DMSO was diluted to a final concentration of 0.5 µg/mL. For the treatment, freshly hatched L1 larvae were grown on normal NGM plates seeded with OP50 (no tunicamycin) until the L4 stage. Infections were carried out as described above, except that the HP plates contained 0.5 µg/mL tunicamycin or an equal concentration of DMSO. For injection experiments, worms were grown on OP50-seeded NGM plates until they were injected on the first day of adulthood (as described above). After the injections, the worms were transferred to new OP50-seeded NGM plates containing the same concentration of tunicamycin. Imaging of live worms was performed using a Zeiss Axio ZoomV.16 microscope.
RT-qPCR.
Primers for assessment of UPR ER activation were published earlier (Richardson et al., 2010) .
Other primers used: lys-7 GTCTCCAGAGCCAGACAATCC; CCAGTGACTCCACCGCTGTA C14C6.5 CGGATACTGTGGCTCC; TATTTGCAATAACCGCATGT dct-17 GATGACTTCACATGTCCT; AGACATCGTACACTGCT T19D12.3 CTCACACGGATTATTACGG; AATAAGACCATCGGAAACTG Following total RNA extraction using the RNeasy mini-kit (Qiagen), complementary DNA was production using the Superscript II protocol (Invitrogen). Quantitative real-time (RT-qPCR) was carried out using Biorad CFX96 real-time PCR machines with SYBR Green I for amplification quantification (Sigma) and
Platinum Taq polymerase (Invitrogen/ Thermo Fisher, Waltham, MA). That specific products were generated was confirmed via melting curve analysis. For data analysis, the comparative C T (2 -ΔΔC T ) method (Livak and Schmittgen, 2001) was used, where 2 -ΔΔC T = [(C T gene of interest -C T internal control) sample A) -(C T gene of interest -C T internal control sample B)]. Expression levels were normalized using the actin (act-1) and tubulin (tbg-1) genes as internal controls and standard deviations were calculated as in (Schmittgen and Livak, 2008) . N-acetylglucosamine treatment. N-acetylglucosamine (GlcNAc) (Sigma) dissolved in water at a stock concentration of 500 mM. Worms were grown on OP50-seeded NGM plates until they were injected on the first day of adulthood as described above. After the injections, the worms were transferred to new OP50seeded NGM plates containing a final concentration of 10 mM GlcNAc. Pumping was scored daily as described above.
Transmission electron microscopy. Sample preparation was performed as in (Hall et al., 2012) . Briefly, worms were removed from food and fixed in 0.8% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.3. Worms were then treated with 0.8% OsO 4 in the same buffer. Worms were washed to remove glutaraldehyde and incubated in 2% OsO 4 in 0.1 M sodium cacodylate buffer for 24 h at 4 °C. Worms were then embedded in 2% agarose and dehydrated via treatment with increasing concentrations of ethanol (50% -100%) followed by embedding in Epon before preparation of thin slices for imaging. Microscopy was performed using a Zeiss EM109 electron microscope (Zeiss, Oberkochen, Germany). 
